2022年12月22日

Innovaccer Inc.宣布获得1.5亿美元E轮融资，估值32亿美元，主要得益于客户对Innovaccer健康云的快速采用。这轮融资由Mubadala Capital领投，现有投资者包括B Capital Group、微软M12基金、OMERS Growth Equity、Dragoneer、Steadview Capital、Tiger Global Management，以及新投资者Whale Rock Capital Management、Avidity Partners和Schonfeld Strategic Advisors。Innovaccer的E轮融资使该公司的总融资超过3.75亿美元。当世界各地的医疗保健组织正在迅速数字化和改变他们提供患者护理的方式时，Innovaccer已经开始了一项使命，即连接和管理世界医疗保健信息，使其可访问和有用。Innovaccer成立于2014年，已经建立了Innovaccer健康云，这是一个由领先的医疗保健组织(包括Orlando Health, MercyOne和CommonSpirit Health)使用的完整软件平台，它统一了以前孤立的数据，帮助他们以更低的成本实现更好的医疗质量。Innovaccer联合创始人兼首席执行官Abhinav Shashank表示:“我们已经到达了医疗保健的转折点，分散的、按服务收费的‘疾病护理’正在让位于一个综合的、基于价值的预防性护理的新世界。”“电子健康记录(EHR)将医疗保健带入了数字化世界，但由于其严格的架构和缺乏互操作性，在许多方面它已经成为数字化转型的障碍。提供商、支付方和生命科学公司都认识到迫切需要一个新的开放平台，将所有医疗保健数据汇集在一起，提供患者的单一视图，并在整个患者过程中实现无摩擦的护理。这是每个人都想要的健康未来，这正是我们通过Innovaccer健康云所构建的。Mubadala Capital美国风投业务合伙人兼主管Alaa Halawa表示:“自2019年以来，我们一直是Innovaccer的投资者，并相信该公司拥有所有必要的支柱，可以定义提供商、支付款人和生命科学公司应该如何实施健康云的新黄金标准。” “Hundreds of tech companies have tried to create a common data framework to connect the healthcare industry, but they all fell short due to extreme industry complexities or technology challenges. But in just a few short years, Innovaccer has built the most successful data activation platform in the healthcare industry as proven by record rates of industry adoption. Innovaccer is likely the first and only company since the invention of the EHR that has the opportunity to unify the healthcare ecosystem.” Innovaccer achieves critical mass in the healthcare ecosystem To date, Innovaccer has signed more than 50 customers, including recent wins with One Medical, Roche, CommonSpirit Health, Franciscan Health, Dayton Children’s Health Partners, St. Luke’s Health System, Sentara Healthcare, Adventist Health, Children’s Health Alliance, Premier Health, Atlantic Health System, Providence, Cityblock Health, Florence Health, and Zus Health, among others. Innovaccer’s ability to help its customers accelerate their transformation and innovation goals is at the core of its value proposition. “Our collaboration with Innovaccer is creating a new generation of clinical decision support tools across a wide range of use cases—from antimicrobial stewardship to oncology—that will empower clinicians to deliver more precise, personalized care,” said Sukhveer Singh, Global Head of Healthcare Insights, Roche Information Solutions. “We see huge potential to create new value for patients and clinicians. The Innovaccer Health Cloud will allow us to accelerate time-to-market and build perpetual innovation into our solution portfolio, positioning Roche to extend our legacy of clinical innovation.” Innovaccer plans to use its new funding to invest in R&D and recruit new hires as it rapidly scales its customer experience, product, and engineering talent. The company intends to release a new portfolio of Innovation Accelerators in 2022 that will help healthcare organizations tackle the most common and high-impact use cases in a fraction of the time associated with traditional methods and technologies. Share this article: